David Rosa's Insider Trades & SAST Disclosures
David Rosa's most recent trade in Eastern Bankshares Inc. was a trade of 10,000 Common Stock done at an average price of $15.4 . Disclosure was reported to the exchange on March 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Rosa.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eastern Bankshares Inc. | R. David Rosato | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 15.40 per share. | 11 Mar 2025 | 10,000 | 20,000 | - | 15.4 | 154,000 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.00 per share. | 05 Mar 2025 | 14,625 | 233,807 (0%) | 0% | 77.0 | 1,126,109 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.46 per share. | 05 Mar 2025 | 14,625 | 240,063 (0%) | 0% | 59.5 | 869,635 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.47 per share. | 05 Mar 2025 | 8,369 | 225,438 (0%) | 0% | 557.5 | 4,665,452 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.58 per share. | 05 Mar 2025 | 8,140 | 231,923 (0%) | 0% | 557.6 | 4,538,691 | Common Stock |
| Eastern Bankshares Inc. | R. David Rosato | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 12,408 | 12,408 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 7,518 | 222,153 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 3,729 | 219,182 (0%) | 0% | 563.8 | 2,102,298 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 1,503 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 223,657 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 746 | 222,911 (0%) | 0% | 563.8 | 420,572 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 9,155 | 9,155 | - | - | Restricted Stock Units - 2-26-2025 | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,816 | 11,447 | - | - | Restricted Stock Units - 2-26-2024 | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,816 | 216,527 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 1,892 | 214,635 (0%) | 0% | 573.7 | 1,085,516 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,710 | 0 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,710 | 213,559 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 848 | 212,711 (0%) | 0% | 573.7 | 486,532 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 18 Feb 2025 | 71,325 | 1,063,747 | - | 1.2 | 82,737 | Common Stock |
| BioRestorative Therapies Inc | David A. Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 52,632 | 52,632 | - | - | Stock Option | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,437 | 2,872 | - | - | Restricted Stock Units - 2-28-2023 | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,437 | 212,572 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 582.98 per share. | 10 Feb 2025 | 723 | 211,849 (0%) | 0% | 583.0 | 421,495 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 31 Jan 2025 | 2,239 | 1,135,072 | - | 1.2 | 2,575 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Dec 2024 | 4,697 | 1,137,311 | - | 0.8 | 3,880 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Nov 2024 | 2,239 | 1,142,008 | - | 0.6 | 1,395 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 915 | 211,080 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,980 | 211,995 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,980 | 213,975 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 31 Oct 2024 | 2,239 | 1,144,247 | - | 1.0 | 2,172 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 30 Sep 2024 | 4,697 | 1,146,486 | - | 1.0 | 4,650 | Common Stock |
| Eastern Bankshares Inc. | R. David Rosato | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 34,070 | 34,070 | - | - | Restricted Stock Unit | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 31 Aug 2024 | 2,239 | 1,151,183 | - | 0.8 | 1,783 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 31 Jul 2024 | 2,239 | 1,153,422 | - | 0.7 | 1,679 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 30 Jun 2024 | 4,697 | 1,155,661 | - | 0.8 | 3,758 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 1,359 | 216,644 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 1,359 | 4,074 | - | - | Restricted Stock Units - 6-12-23 | |
| Intuitive Surgical Inc | David J. Rosa | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 417.61 per share. | 10 Jun 2024 | 689 | 215,955 (0%) | 0% | 417.6 | 287,733 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 31 May 2024 | 2,239 | 1,160,358 | - | 0.9 | 2,082 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2024 | 2,507 | 215,285 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 30 Apr 2024 | 2,239 | 1,162,597 | - | 1.1 | 2,530 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 21 Apr 2024 | 19,673 | 1,164,836 | - | 1.2 | 22,624 | Common Stock |
| Berkshire Hills Bancorp Inc. | R. David Rosato | SEVP - Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. | 01 Apr 2024 | 815 | 1,845 (0%) | 0% | 22.3 | 18,134 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 31 Mar 2024 | 2,239 | 1,184,509 | - | 1.2 | 2,687 | Common Stock |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 2,253 | 218,193 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | Rosa J. David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 2,253 | 0 | - | - | Restricted Stock Units | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 29 Feb 2024 | 2,239 | 1,186,748 | - | 1.2 | 2,709 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,504 | 3,007 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,504 | 218,555 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David Rosa J. | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.59 per share. | 29 Feb 2024 | 1,142 | 217,051 (0%) | 0% | 386.6 | 441,486 | Common Stock |
| Intuitive Surgical Inc | Rosa J. David | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.59 per share. | 29 Feb 2024 | 763 | 217,792 (0%) | 0% | 386.6 | 294,968 | Common Stock |
| Intuitive Surgical Inc | David Rosa J. | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 15,263 | 15,263 | - | - | Restricted Stock Units - 2-26-2024 | |
| Intuitive Surgical Inc | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,710 | 1,710 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | Rosa David J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,710 | 216,807 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David Rosa J. | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 389.77 per share. | 26 Feb 2024 | 867 | 215,940 (0%) | 0% | 389.8 | 337,931 | Common Stock |
| NeuroOne Medical Technolog... | David Rosa A. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 663,497 | 1,188,987 | - | 0 | Common Stock | |
| BioRestorative Therapies Inc | David Rosa A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 79,646 | 79,646 | - | - | Stock Option | |
| Intuitive Surgical Inc | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,437 | 215,826 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical Inc | David Rosa J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,437 | 4,309 | - | - | Restricted Stock Units | |
| Intuitive Surgical Inc | David J. Rosa | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 388.22 per share. | 10 Feb 2024 | 729 | 215,097 (0%) | 0% | 388.2 | 283,012 | Common Stock |
| Intuitive Surgical Inc | Rosa David J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.09 per share. | 07 Feb 2024 | 40,500 | 225,084 (0%) | 0% | 49.1 | 1,988,100 | Common Stock |
| Intuitive Surgical Inc | David Rosa J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 40,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 28,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.34 per share. | 07 Feb 2024 | 28,125 | 230,089 (0%) | 0% | 49.3 | 1,387,780 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 28,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.02 per share. | 07 Feb 2024 | 28,125 | 200,734 (0%) | 0% | 51.0 | 1,434,814 | Common Stock |
| Intuitive Surgical Inc | Rosa David J. | President | Sale of securities on an exchange or to another person at price $ 389.28 per share. | 07 Feb 2024 | 23,120 | 201,964 (0%) | 0% | 389.3 | 9,000,195 | Common Stock |
| Intuitive Surgical Inc | Rosa J. David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.11 per share. | 07 Feb 2024 | 22,050 | 185,449 (0%) | 0% | 57.1 | 1,259,300 | Common Stock |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,050 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.23 per share. | 07 Feb 2024 | 22,050 | 176,299 (0%) | 0% | 59.2 | 1,305,973 | Common Stock |
| Intuitive Surgical Inc | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,050 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | Rosa J. David | President | Sale of securities on an exchange or to another person at price $ 389.23 per share. | 07 Feb 2024 | 16,150 | 184,584 (0%) | 0% | 389.2 | 6,286,026 | Common Stock |
| Intuitive Surgical Inc | David Rosa J. | President | Sale of securities on an exchange or to another person at price $ 389.29 per share. | 07 Feb 2024 | 15,700 | 214,389 (0%) | 0% | 389.3 | 6,111,784 | Common Stock |
| Intuitive Surgical Inc | Rosa J. David | President | Sale of securities on an exchange or to another person at price $ 389.29 per share. | 07 Feb 2024 | 12,900 | 163,399 (0%) | 0% | 389.3 | 5,021,798 | Common Stock |
| Intuitive Surgical Inc | J. David Rosa | President | Sale of securities on an exchange or to another person at price $ 389.30 per share. | 07 Feb 2024 | 12,840 | 172,609 (0%) | 0% | 389.3 | 4,998,665 | Common Stock |
| NeuroOne Medical Technolog... | A. David Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 31 Jan 2024 | 2,239 | 525,490 | - | 1.3 | 2,799 | Common Stock |
| Berkshire Hills Bancorp Inc. | Rosato R. David | SEVP - Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,348 | 6,348 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Technolog... | A. Rosa David | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 31 Dec 2023 | 2,239 | 527,729 | - | 1.6 | 3,538 | Common Stock |
| Intuitive Surgical Inc | J. Rosa David | President | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2023 | 1,572 | 154,140 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 30 Nov 2023 | 2,239 | 529,968 | - | 1.5 | 3,247 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,619 | 8,619 | - | - | Non-Qualified Stock Option (right to buy) | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 31 Jul 2023 | 2,239 | 541,163 | - | 1.0 | 2,284 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 30 Jun 2023 | 2,239 | 543,402 | - | 1.2 | 2,687 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 16,297 | 16,297 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 5,433 | 5,433 | - | - | Restricted Stock Units | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 31 May 2023 | 2,239 | 545,641 | - | 1.2 | 2,709 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. | 30 Apr 2023 | 2,239 | 547,880 | - | 1.5 | 3,448 | Common Stock |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 91,500 | 91,500 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 91,500 | 550,119 | - | 0 | Common Stock | |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.64 per share. | 21 Apr 2023 | 54,000 | 183,276 (0%) | 0% | 42.6 | 2,302,382 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.64 per share. | 21 Apr 2023 | 54,000 | 196,476 (0%) | 0% | 42.6 | 2,302,382 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 54,000 | 54,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 54,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Sale of securities on an exchange or to another person at price $ 297.92 per share. | 21 Apr 2023 | 40,800 | 142,476 (0%) | 0% | 297.9 | 12,155,173 | Common Stock |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Sale of securities on an exchange or to another person at price $ 299.20 per share. | 21 Apr 2023 | 40,764 | 155,712 (0%) | 0% | 299.2 | 12,196,446 | Common Stock |
| Berkshire Hills Bancorp Inc. | R. David Rosato | SEVP - Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 7,981 | 7,981 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Technolog... | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.61 per share. | 31 Mar 2023 | 2,239 | 458,619 | - | 1.6 | 3,605 | Common Stock |
| Biotricity Inc | David A. Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2023 | 75,930 | 474,683 | - | - | Option (right to buy) | |
| Intuitive Surgical Inc | David J. Rosa | EVP Chief Strategy & Growth Of | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,619 | 8,619 | - | - | Non-Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges